Tower Research Capital LLC (Trc) Volitionrx LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Volitionrx LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,288 shares of VNRX stock, worth $3,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,288
Previous 12,663
58.24%
Holding current value
$3,331
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding VNRX
# of Institutions
29Shares Held
24.2MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY11.7MShares$7.37 Million5.2% of portfolio
-
Armistice Capital, LLC New York, NY8.49MShares$5.35 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA765KShares$481,8810.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$325,1250.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $36.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...